Skip to main content
    O

    OrganiGram Holdings Inc (OGI)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $0.72
    -0.11 (-12.71%)

    Market Cap: $116.93M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    OrganiGram Holdings Inc (OGI) Valuation Multiples

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    OrganiGram Holdings (OGI) trades at 0.4x sales and 0.3x book value. Its P/S of 0.4x is below its 5-year median of 1.1x.

    Current Multiples

    OGI reports in CAD, so earnings multiples appear here only when its per-share earnings can be confirmed.

    MultipleValue
    P/E (trailing)N/A
    Forward P/EN/A
    Price to sales0.4x
    Price to book0.3x
    EV/EBITDA8.1x
    PEGN/A
    FCF yield-23.5%
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/B is 62.5% below 0.8x.

    MultipleCurrent5-year median10-year median
    P/S0.4x1.1xN/A
    P/B0.3x0.6x0.8x
    Medians of month-end values through Oct 2026: 50 to 60 months (5-year) and 110 months (10-year).

    Valuation History

    Over the 6 of the 10 year ends shown that have a P/S, its P/S ranged from 0.9x in 2023 to 43.9x in 2017.

    Year endPriceP/SP/B
    2025$1.681.1x0.9x
    2024$1.611.2x0.8x
    2023$1.310.9x0.5x
    2022$3.201.4x0.7x
    2021$7.00N/A0.4x
    2020$5.324.5x1.4x
    2019$9.80N/AN/A
    2018$14.27N/A2.4x
    2017$12.9443.9x4.9x
    2016$8.60N/A0.8x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported.

    P/E history is shown only for companies that report in US dollars.

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About OGI

    Is OGI stock overvalued?

    GNG's valuation label for OGI is Undervalued.

    What is OGI's price to sales ratio?

    OrganiGram Holdings has a price to sales ratio of 0.4x.